Vancomycin is a powerful antibiotic against Gram-positive bacteria that inhibits cell-wall synthesis by binding with high affinity to peptidoglycan precursors. Resistance to vancomycin is due to acquisition of operons encoding, among other enzymes, the zinc-dependent D,D-peptidases VanX, VanY, or VanXY, which catalyze the removal of the drug targets. Structural characterization of VanXY elucidates the molecular basis of their specificity toward vancomycin-susceptible precursors and explains the dual function of VanXY. These studies highlight the striking plasticity of peptidoglycan-modifying enzymes to evolve to antibiotic resistance proteins. They also provide the molecular framework for development of D,D-peptidase inhibitors that may help to curb vancomycin resistance.
T he emergence of high-level resistance to vancomycin, a last resort antibiotic against Gram-positive bacteria, in Enterococcus spp. and its spread to methicillin-resistant Staphylococcus aureus is a serious threat to public health (1) (9) . Appropriate to its role in resistance, the VanY enzyme shows carboxypeptidase activity against pentapeptide[D-Ala] but lacks activity against D,D-dipeptide substrates (5, 10) . The VanXY C enzyme is selective against resistant dipeptide and pentapeptide peptidoglycan substrates ending in D-Ser (8) . Finally, the VanXY G enzyme, first assigned as a dual substrate active "XY" enzyme by sequence similarity (11) , was later shown to lack D,D-pentapeptidase activity typical for bona fide VanXY enzymes (12) . The molecular determinants responsible for such diversity of substrate specificity among Van D,D-peptidases are unknown, limiting the understanding of their evolution and hampering the development of inhibitors that could be used in combination with glycopeptides.
With the exception of VanY D , which is a penicillin-binding protein (13) , all VanX, VanY, and VanXY D,D-peptidases are zinc-dependent enzymes classified into the metallopeptidase clan MD, family M15, according to the MEROPS database (14) . Within clan MD, multiple families of enzymes, including M15 representatives, are involved in bacterial cell wall metabolism (15) . Three members of this family have been structurally characterized: zinc D-Ala-D-Ala carboxypeptidase from Streptomyces albus (16) (subfamily M15A), bacteriophage L-Ala-D-Glu peptidase PLY500 (17) (subfamily M15C), and VanX (subfamily M15D) from Enterococcus faecium (18) . These enzymes display a common core tertiary fold built on a central antiparallel β-sheet arrayed with multiple α-helices on either face of the β-sheet. The fold
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contains two consensus motifs that form the active site, His-X (6)-Asp and Glu-X(2)-His, with a zinc ion coordinated by the histidine and aspartate residues. In addition, the structure of VanX revealed a small and constricted active site that explains its specificity toward the D-Ala-D-Ala substrate (18) . The VanY and VanXY enzymes belonging to subfamily M15B remain structurally uncharacterized.
Given the evolution toward dual substrate specificity of VanXY enzymes, their importance in resistance, and their sequence and functional diversity, we undertook their detailed structural and functional characterization. We determined the crystal structures of VanXY C and VanXY G and performed extensive mutagenesis analysis. Our data led to the identification and characterization of the molecular features responsible for their substrate specificities and demonstrated an exceptional diversification and plasticity within their common metallopeptidase fold in response to drug selective pressure. Table S1 ). The VanXY C D59S structure features two polypeptide chains associated into a dimer (Fig. S1A) (15, 18, 19) ; the presumed catalytic acid/base, Glu153 (Glu164); and an arginine, Arg62 (Arg74), which stabilizes the negative charge at the tetrahedral center in the transition state (15, 18, 19) . Features unique to VanXY include the presence of residues Asp59 (Ser71) and Gln67 (Gln79) that interact on either side of the active site arginine to stabilize its conformation. Both VanXY enzymes possess a prominent loop between β4 and α5 that extends away from the core D,D-peptidase domain and forms a cap over the active site.
Results
According to the VanXY G structure, the N-and C-terminal sequences (residues 1-32 and 186-250) ( (Table S1 ). A mixture of the four diastereoisomers of PHY inhibited VanXY C and VanXY G in a competitive manner with K i values of 60 and 324 μM, respectively (Fig. S4 ). We also determined the structure of VanXY C D59S in complex with its substrate D-Ala-D-Ala and product D-Ala ( Fig. 2 C-E) to 2.0 and 2.25 Å, respectively. The enzyme•substrate complex structure was captured by replacing the VanXY C D59S active site zinc with copper, which has been shown to inhibit the activity of this enzyme (8) (SI Materials and Methods).
The position of the inhibitor was identical in both structures and similar to that of the D-Ala-D-Ala substrate, with the N termini of both ligands pointed outwards to the opening of the VanXY active site cavity and their C termini located deep in the catalytic site ( Fig. 2C and Fig. S3 ). Due to the racemic mixture for crystallization, PHY and its (L,D)-diastereoisomer were observed in both VanXY complexes (Fig. S5) . However, the (L,D)-diastereoisomer will not be discussed further because VanXY C was 384-fold less efficient in hydrolyzing L-Ala-D-Ala than D-Ala-D-Ala and had no activity against the (L, L)-or (D, L)-diastereoisomers (Table S2 ). The two oxygens of the tetrahedral phosphate of PHY chelated the Zn 2+ ion, mimicking the expected state of the tetrahedral hydrolysis intermediate (Fig. S5) (9, 18) . Similarly, the peptide oxygen of D-Ala-D-Ala formed an interaction with the Cu 2+ ion (Fig. 2D ). In line with this observation, the side chain of Arg62 (Arg74) formed a bidentate interaction with the other phosphate oxygen of PHY (Fig. S3) , while remaining hydrogen-bonded to Gln67 (Gln79) and Ser59 (Ser71).
The positions of the two methyl groups of PHY and of D-Ala-D-Ala were defined by hydrophobic pockets in the VanXY C active center and revealed the molecular mechanism for selectivity toward hydrolysis of the D-Ala-D-Ala target. D-Ala-4 was accommodated into a pocket formed by Leu70 (Ile82), Val87 (Val99), and Leu113 (Phe124) (Fig. 3A) and D-Ala-5 by Ala88 (Ala100), Tyr140 (Tyr150), and Ile150 (Ile161) (Fig. 3B) . Importantly, modeling any larger sidechain in either position of D-Ala-D-Ala or PHY led to steric clashes with its binding pocket in both VanXY structures, suggesting strict selectivity for alanine at both positions of the substrate. The carboxylates of D-Ala-D-Ala and PHY occupied the deepest part of the active site and were oriented by interactions with Gln67 (Gln79), Arg62 (Arg74), and Ser93 (Ser105) (Figs. 2D and 3B ). Gln67 (Gln79) is conserved only in the M15B subfamily (Fig. S2 ), suggesting that this is a key residue for substrate specificity.
The position of D-Ala in the VanXY C D59S •product complex ( (Fig. 4A) , with both enzymes interacting with their respective substrates in the same vicinity of the active center (Fig. 4B) . However, comparative analysis of the VanXY and VanX D-Ala-D-Ala binding sites revealed important differences. The VanXY•D-Ala-D-Ala complex displayed two distinctive cavities leading to the active center (Fig. 2C) . One of the cavities (cyan in Figs. 2C and 4B ) is constricted by Ala88 (Ala100), Tyr140 (Tyr151), and Ile150 (Ile161) Fig. 4B ). In VanX, the N terminus of D-Ala-D-Ala and the sidechain of Ala-1 were bound into this cavity's deepest region, with the C terminus of the substrate facing solvent (18) . The second cavity (magenta in Figs. 2C and 4B) in the VanXY active center was relatively larger and had no equivalent in VanX (Fig. S6) . This cavity accommodated D-Ala-D-Ala or PHY with their C termini and D-Ala-5 bound in the depth of this pocket and their N termini facing toward solvent. Of note, the VanXY active site larger cavity was capped by the prominent β4-α5 loop, suggesting its potential role in mediating substrate interactions. Overall, these observations indicate that, whereas VanXY enzymes retained a cavity that is seen in VanX, the binding of the dipeptide substrate in these enzymes is shifted to a distinct and unique region of the active center.
Comparison (Fig. 5C and Table S3 ). To identify the molecular determinants responsible for these differences, active site residues were mutated in VanXY C and VanXY G (Table  S4) , and the activity of these variants was measured against the two substrates ( Fig. 5C and Table S3 ). Mutation of the catalytic base Glu153 (Glu164) and of the transition state-stabilizing Arg62 (Arg74) severely abrogated VanXY activity, confirming their essentiality (Table S3) . We observed a similar effect with mutation of Gln67 (Gln79) to glutamate, suggesting that the amide nitrogen was also critical for VanXY catalysis. Mutation of VanXY C Asp59 to serine resulted in a sixfold lower catalytic efficiency whereas the reciprocal mutation of VanXY G Ser71 to aspartate had an opposite Table S3 .
effect, yielding a twofold increase. These results are in line with the structural analysis suggesting that this VanXY C residue coordinates the catalytic arginine and plays an important role in substrate positioning. The fact that the Ser71Asp mutant of VanXY G was not sufficient to match the level of D,D-dipeptidase activity indicates that other active site residues contribute to this difference.
Next, we targeted the binding pocket for the N-terminal alanine of the substrate. The VanXY C Leu70Glu mutation led to a significant drop in activity against both substrates whereas substitution of the corresponding residue Ile82 to alanine in VanXY G resulted in threefold higher catalytic efficiency against D-Ala-D-Ala compared with the wild-type enzyme. This result points to the importance of a hydrophobic sidechain at this position and suggests that the smaller alanine sidechain may provide a catalytic advantage in interaction with substrate's alanine. The VanXY G mutant Ile125Ala had a drastic decrease in catalytic activity. At the equivalent position, the VanXY C mutant Ile114Glu retained only 12% activity against D-Ala-D-Ala but showed a fivefold higher catalytic efficiency against pentapeptide [D-Ala]. Mutation Leu113Glu in VanXY C reduced D,D-dipeptidase activity of this enzyme by twofold. Notably, both Leu113 (Leu124) and Ile114 (Ile125) residues belong to the β4-α5 loop, which is prominently exposed near the VanXY-specific substrate binding cavity. The drastic changes in activity prompted by these mutations suggest that this structural element may be involved in D,D-dipeptidase activity.
Within the binding pocket for the C-terminal alanine of the substrate, mutation of VanXY C Ala88 to either leucine or aspartate severely compromised the D,D-dipeptidase activity whereas the D,D-pentapeptidase activity was affected by Ala88Asp but not by Ala88Leu substitution (Table S3) . Mutation of VanXY C Ile150 resulted in abrogation of both activities and demonstrated its importance for the bisubstrate activity of VanXY C .
Combined mutagenesis and biochemical analysis points to the prominent β4-α5 loop (VanXY C D59S residues 107-120) as a VanXY-specific structural element involved in interactions with the substrates. This loop formed one face of the VanXY-specific cavity proximal to the PHY binding site (Fig. 2C ), adopted different conformations according to the bound ligand (Fig. 5A) , and possessed significant flexibility, as judged by the corresponding B-factors (Fig. S7) . To further test its potential role in VanXY activity, we probed the other residues forming this loop and those interacting with it by mutagenesis. In agreement with our previous results, mutations Asn78Phe, Leu113Glu, or Ile114Glu, resulted in three-to ninefold increases in VanXY C catalytic efficiency and up to threefold greater affinity for pentapeptide[D-Ala] (Fig. 5C and Table S3 ).
To test whether the rise in activity was due to destabilization of the β4-α5 loop by mutagenesis, we introduced two deletions in this region, VanXY C Δ106-117 and Δ110-115. The deletant derivatives demonstrated, respectively, 20-and 245-fold decreases in D,D-dipeptidase activity (Fig. 5C and Table S3 ). The VanXY C Δ106-117 variant showed a threefold decrease in D,D-pentapeptidase activity whereas the VanXY C Δ110-115 mutant completely lost activity against this substrate. These results confirmed the key role played by the β4-α5 loop, which we now term the bisubstrate selectivity loop, in the dual activity of VanXY. In the absence of a costructure between VanXY C and pentapeptide [D-Ala], we speculate that the observed increases in catalytic efficiency of VanXY bisubstrate selectivity loop mutants were due to introduction of additional interactions with this substrate.
Discussion
Metallopeptidases are important contributors to recycling and metabolism of peptidoglycan and are essential in glycopeptide resistance. Due to antibiotic selection, enzymes from subfamilies M15D and M15B evolved as resistance-conferring proteins due to their activities in reducing the proportion of peptidoglycan precursors containing the glycopeptide-susceptible terminal D-Ala moiety by hydrolyzing D-Ala-D-Ala and pentapeptide[D-Ala], respectively. The evolution of VanXY, most similar to members of the M15B subfamily yet capable of mediating both dipeptidase and pentapeptidase reactions, is an example of the emergence of bifunctional antibiotic resistance enzymes (22) . Bacteria might gain several advantages from this strategy, such as greater flexibility in enzyme activity, greater reaction efficiency, more efficient use of transcription and translation, coupled gene regulation, or ease of movement of mobile genetic resistance elements (22) .
We provide insights into the structure, function, and evolution of VanXY D,D-peptidases, revealing the mechanism of dual specificity of this class of enzymes to mediate vancomycin resistance. This adaptation mechanism is centered on a mobile loop, appropriately positioned over the catalytic center and participating in both the D,D-dipeptidase and D,D-pentapeptidase reactions. Such flexible structural elements often mediate substrate selectivity and support diverse enzymatic reactions, including peptide hydrolysis (23, 24) . In the case of VanXY C , the bisubstrate selectivity loop may alter its conformation based on the size of the substrate, providing the necessary chemical environment to accommodate its distinct substrates.
Structure-based multiple sequence alignment ( (25, 26) , and/or self-resistance of a glycopeptide producer, such as VanY n (27) . This evolutionary model is consistent with sequence analysis and extensive phylogenetic reconstruction (Fig. S8) showing that VanXY are most related to VanY enzymes, and speculation that they would share a substrate binding site less constricted than that of VanX (7). It is also in line with a general trend for antibiotic resistance proteins, where an ancestral "protoresistance" enzyme scaffold with a housekeeping function is recruited for resistance through structural changes that affect its substrate specificity or activity (28) . To the best of our knowledge, elucidation of the structural adaptations of the M15 metallopeptidase fold in response to antibiotic pressure is the first such observation for this enzyme family.
Structural analysis also showed that VanXY enzymes are optimized to select for D-Ala at the terminal position of the peptidoglycan substrates. The main catalytic residues of the VanX and VanXY families superimpose well, implying a conserved hydrolysis mechanism. However, the VanXY active site features subtle differences, such as acquisition of the Gln67/Gln79 residue that positions the carboxylate of the substrates. These features would position the unsuitable substrate into the hydrophobic environment of the VanXY D-Ala binding pockets, enabling discrimination against D-Ser at the C-terminal position. Analysis of VanY sequences indicates that these enzymes also contain this key glutamine residue and the general characteristics of this hydrophobic selectivity pocket, suggesting that they also rely on these interactions for D,D-carboxypeptidase activity.
Although our data provided significant insights into the molecular function of VanXY enzymes, several aspects of VanXY G activity remain to be clarified. Specifically, it is unclear why VanXY G lacks D,D-pentapeptidase activity and has relatively poor D,D-dipeptidase activity, even though VanXY G and Van-XY C have very similar interactions with PHY.
Another intriguing structural feature is the presence of a secondary domain in VanXY G formed by residues 1-32 and 186-250. The specific role of this domain remains to be determined. Phylogenetic analysis of VanXY enzymes placed VanXY G closest to the VanY enzymes and suggested that the sequence corresponding to the VanXY G secondary domain is partially conserved in these enzymes (Figs. S2 and S8 ). Given that VanY enzymes are membrane-associated whereas VanXY enzymes are not, one might speculate that the secondary domain might have a role in membrane association. In this scenario, presence of this domain in VanXY G could be a relic of the evolution of VanXY from VanY enzymes.
Finally, the molecular structures of the VanXY and VanY enzymes pave the way for the design of inhibitors that would target vancomycin resistance. Given that the shallow nature of the VanX active site posed challenges in designing potent inhibitors (29) , the less constricted pentapeptide[D-Ala] binding sites of VanXY or VanY suggest that these enzymes are more attractive targets for inhibitor development. The presented crystal structures provide the necessary molecular framework for searches for suitable inhibitory compounds.
Our data demonstrate that the D,D-peptidase fold is able to expand its role in vancomycin resistance as a result of specific structural changes in its active site. This study highlights the remarkable adaptability of this enzyme class to accommodate widely different peptidoglycan substrates. This observation underscores the adaptability of microorganisms in response to antibiotic challenge and demonstrates the susceptibility of established antibiotics long thought to be exempt from resistance.
Materials and Methods
VanXY proteins were purified using N-terminal His-tags from Escherichia coli BL21-CodonPlus (DE3)-RIPL cells. Site-directed mutagenesis was performed using the oligonucleotide pairs in Table S1 . All crystals were grown using hanging-drop vapor diffusion. Crystals of PHY complexes were obtained by soaking into apoprotein crystals. Crystals of the Van 
